Brenton Karl Ahrens

Filings by Brenton Karl Ahrens span 2 companies, the busiest being Iterum Therapeutics plc and Durata Therapeutics, Inc. The record holds 19 filings, for trades running from 24 July 2012 to 20 September 2022.

Both buying and selling appear: 2 purchases worth €9.8M, against 9 sales worth €238k. The net balance comes to €9.6M on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 2 option exercises. 2022 to date brings no purchases and 9 sales.

The record was last updated on 20 September 2022 with an open-market sale (€26k) in Iterum Therapeutics plc. The clock since the last published purchase (30 May 2018) now reads 3,069 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.